Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection.
作者信息
Fabregat J, Fradera R, Figueras J, Rafecas A, Torras J, Martinez LaCasa J, Baliellas C, Casais L, Jaurrieta E
机构信息
Liver Transplant Unit, Universidad de Barcelona, Spain.
出版信息
Transplant Proc. 1994 Oct;26(5):2697-9.
PMID:7940845
Abstract
摘要
相似文献
1
2
Clinical results of quadruple drug immunosuppression in liver transplantation.肝移植中四联药物免疫抑制的临床结果
Transplant Proc. 1992 Feb;24(1):148-9.
3
Optimal immunosuppressive clinical regimen in liver transplantation.肝移植中的最佳免疫抑制临床方案。
Transplant Proc. 1994 Oct;26(5):2676-8.
4
Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.诱导免疫抑制治疗与肝移植后低排斥率相关。
Clin Transplant. 1997 Aug;11(4):328-33.
5
Immunosuppressive requirements for small bowel/liver transplantation.小肠/肝脏移植的免疫抑制需求
Transplant Proc. 1993 Feb;25(1 Pt 2):1204-5.
6
Cyclosporine Neoral in liver transplant recipients.肝移植受者使用新山地明（环孢素软胶囊）。
Transplant Proc. 1994 Oct;26(5):2949-52.
7
Incidence and patterns of rejection using different induction therapies in liver transplant recipients.肝移植受者中使用不同诱导疗法的排斥反应发生率及模式
Transplant Proc. 1994 Oct;26(5):2669-71.
8
Cytomegalovirus infection in pediatric heart transplantation.
Transplant Proc. 1993 Feb;25(1 Pt 2):1423-5.
9
10
Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
Transplant Proc. 1996 Aug;28(4):2107-8.
引用本文的文献
1
Liver transplantation across Rh blood group barriers increases the risk of biliary complications.跨越Rh血型屏障进行肝移植会增加胆道并发症的风险。
J Gastrointest Surg. 2007 Apr;11(4):458-63. doi: 10.1007/s11605-007-0116-0.
Zotero 插件